ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2802

Non-Canonical NF-Kappab Signaling Promotes Angiogenesis in a Novel 3D Spheroid Model of Rheumatoid Arthritis Synovial Inflammation

Chrissta X. Maracle1, Boy Helder2, Ae-Ri Noort1, Corine van der Horst3 and Sander W. Tas1, 1Department of Clinical Immunology & Rheumatology and Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 2Department of Clinical Immunology and Rheumatology and Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 3Arthrogen BV, Amsterdam, Netherlands

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Angiogenesis and signal transduction

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis I

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Angiogenesis is regarded as a switch from acute to chronic inflammation and thus plays a crucial role in rheumatoid arthritis disease progression. This process is highly complex, involving interactions between several cell types in the inflamed synovium. Many of the current in vitro models of angiogenesis focus solely on endothelial cells (EC) and do not include interactions with other cell types. RA synovial fibroblasts (RASF) are important contributors to angiogenesis in synovial inflammation, and therefore a model including both RASF and EC would more accurately represent the pathophysiology of RA angiogenesis. We previously demonstrated that NF-κB inducing kinase (NIK) dependent non-canonical NF-κB signaling can induce angiogenesis in EC. This has not yet been studied in a co-culture model of angiogenesis.

Objective:

To develop a 3D in vitro model to study the interaction between RASF and EC and to further delineate the role of the non-canonical NF-κB pathway in pathological angiogenesis. 

Methods:

We developed a novel 3 dimensional (3D) model in which human umbilical cord vein EC and RASF were labeled with green or orange cell tracker dye, respectively, and incubated overnight to form spheroids. Subsequently, the spheroids were harvested and plated in a collagen solution, and medium with or without lymphotoxin α1β2 (LT) or LIGHT (both stimuli that induce non-canonical NF-κB signaling via the lymphotoxin beta receptor (LTβR)) or pro-angiogenic growth factors (bFGF/VEGF) was added. After 48 hours, spheroids were fixed and imaged through confocal microscopy. Cumulative EC sprout length and the number of sprouts was quantified using Leica QWin Plus software. To demonstrate NIK dependency of this process, EC were transfected with non-targeting or NIK targeting siRNA before addition into the model and subsequent sprout formation was quantified.

Results:

Confocal analysis of the 3D model showed spheroids containing HUVEC and RASF formed sprouts under all conditions. Both  LT and LIGHT caused significant increases in cumulative sprout length (p<0.05). Interestingly, the total number of sprouts formed by each spheroid also increased significantly. LT and LIGHT induced sprout formation was significantly decreased by siRNA-mediated knockdown of NIK in EC as compared to the non-targeting siRNA controls. 

Conclusion:

Our novel 3D model demonstrates that activation of the non-canonical pathway induces angiogenesis in spheroids of EC and RASF and that this process is strictly NIK dependent.  This suggests that NIK targeting therapeutics may be able to reduce pathological angiogenesis in synovial inflammation and possibly halt disease progression. Further studies to test this, including the use of small molecule pharmacological NIK inhibitors, are currently underway. Of interest, the current 3D model is also optimized to include different subsets of immune cells in order to study their contributions to inflammation-induced angiogenesis, which makes this model a valuable tool for future studies.


Disclosure:

C. X. Maracle,
None;

B. Helder,
None;

A. R. Noort,
None;

C. van der Horst,
None;

S. W. Tas,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/non-canonical-nf-kappab-signaling-promotes-angiogenesis-in-a-novel-3d-spheroid-model-of-rheumatoid-arthritis-synovial-inflammation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology